Keyphrases
Ca2+
100%
Mesangial Cells
100%
Store-operated
100%
A1 Receptor
100%
Extracellular Matrix Deposition
100%
Glucagon-like
100%
Liraglutide
70%
High Glucose
60%
Extracellular Matrix Protein 1 (ECM1)
40%
Protein Production
40%
Fibronectin
30%
Collagen IV
30%
Exendin
30%
Ca2+ Entry
20%
Human Mesangial Cells
20%
Glomerular Mesangial Cells
20%
Diabetic Kidney Disease
20%
Beneficial Effects
10%
Novel Mechanism
10%
Receptor Signaling
10%
Inhibitory Effect
10%
GSK-7975A
10%
Beta-blockers
10%
Channel Function
10%
Health Systems
10%
ORAI1 Protein
10%
Ca2+ Imaging
10%
Receptor Agonist
10%
Renoprotective Effect
10%
Protein Abundance
10%
Exendin-4 (Ex-4)
10%
Renal Protection
10%
Mesangial Matrix
10%
Glucose Effect
10%
Challenges in Healthcare
10%
Medicine and Dentistry
Extracellular Matrix
100%
Calcium Channel
100%
Mesangial Cell
100%
Glucagon Like Peptide 1 Receptor
100%
Calcium Ion
77%
Liraglutide
77%
Extracellular Matrix Protein
44%
Fibronectin
33%
Upregulation
22%
Diabetic Nephropathy
22%
Disease
11%
Health Care
11%
Calcium Release Activated Calcium Channel 1
11%
Exenatide
11%
Glycogen Synthase Kinase
11%
Glucagon-Like Peptide-1 Agonist
11%
Pharmacology, Toxicology and Pharmaceutical Science
Calcium Channel
100%
Glucagon-Like Peptide 1 Receptor
100%
Calcium Ion
77%
Liraglutide
77%
Matrix Protein
44%
Fibronectin
33%
Diabetic Nephropathy
22%
Disease
11%
Glycogen Synthase Kinase
11%
Calcium Release Activated Calcium Channel 1
11%
Glucagon Like Peptide 1 Receptor Agonist
11%
Exendin 4
11%
Biochemistry, Genetics and Molecular Biology
Calcium Channel
100%
Mesangial Cell
100%
Glucagon-Like Peptide 1 Receptor
100%
Liraglutide
70%
Extracellular Matrix Protein
40%
Fibronectin
30%
Upregulation
20%
Calcium Release Activated Calcium Channel 1
10%
Receptor Agonists
10%
Glycogen Synthase Kinase
10%
Immunology and Microbiology
Extracellular Matrix
100%
Calcium Channel
100%
Matrix Protein
80%
Fibronectin
60%
Upregulation
40%
Agonist
20%
Calcium Release Activated Calcium Channel 1
20%